Equity and COVID-19 treatment allocation: A questionable criterion.

Area of Science:

• Medical Ethics
• Public Health Policy
• Health Equity

Background:

• The COVID-19 pandemic highlighted challenges in allocating scarce medical resources.
• Equity-based criteria, prioritizing marginalized groups, have been proposed and adopted in some policies.
• These criteria are defended as addressing medical need and redressing social injustices.

Purpose of the Study:

• To critically analyze the ethical justifications for equity-based allocation schemes in healthcare.
• To evaluate the arguments supporting the prioritization of disadvantaged groups for scarce treatments.
• To present moral objections against such equity-included allocation strategies.

Main Methods:

• Ethical analysis of policy justifications.
• Critique of arguments based on risk factors and remedial justice.
• Philosophical examination of moral principles in resource allocation.

Main Results:

• The arguments defending equity-based allocation as a proxy for medical need are found unconvincing.
• The justification of equity-based allocation as remedial justice is also critically assessed and found wanting.
• The study identifies significant moral reasons to reject these specific equity-focused allocation schemes.

Conclusions:

• Equity-based allocation schemes, as currently defended, lack sufficient ethical grounding.
• Prioritizing specific groups based on historical disadvantage or socioeconomic status for scarce resources raises substantial moral concerns.
• Alternative approaches to resource allocation that do not rely on these contested equity criteria are implicitly suggested.